Information from Industry - Sponsored Supplement
Forget Fibrates for Cardiovascular Risk Reduction: Commentary on the Failure and Implications of the PROMINENT Trial
Developed under the direction and sponsorship of Amarin Pharma, Inc.
May 1, 2023|Family Medicine
In this supplement to Family Medicine, Charles P Vega, MD, and Pamela R Kushner, MD, discuss failure of the PROMINENT trial and implications for use of fibrates to reduce cardiovascular risk.
,false